Background Pancreatic ductal adenocarcinoma (PDAC) is largely refractory to immune checkpoint blockade, owing to its ...

Background Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal cancers due to its aggressive biology and ...

Next-generation instruments improve rare-cell detection, sterility control, biosafety, and throughput for translational ...

IMU Biosciences, a biotechnology company decoding the immune system to pioneer a paradigm shift in how understand, diagnose, and treat disease, and Waters Corporation, a global leader in life sciences ...

Soluble CD137 in health and disease: A systematic review and meta-analysis. Comparative enumeration of circulating tumor cells with PD-L1 overexpression using anti-EpCAM antibody to N-cadherin in ...

Google has announced a new mechanism in Android called Advanced Flow, which will allow sideloading APKs from unverified developers for power users in a more secure manner. The new system, scheduled to ...

Android’s most diehard fans were less than pleased when Google announced plans to limit the sideloading of apps, in an effort to create a more secure platform. The backlash from power users was ...

Google has detailed its upcoming “Advanced Flow” system for Android sideloading, designed to improve security without fully restricting the practice. The new process adds extra steps—like enabling ...

A hot potato: A year after announcing the most significant change to Android in a long time, Google is now introducing a new process aimed at making the mobile platform "open" again. Mountain View ...

Later this year, Google is introducing new Android developer verification. For power users, Android will offer an “advanced flow” to disable the verification requirement. This “advanced flow” is for ...

The one-time ‘advanced flow’ includes 24 hours of cooling off time. The one-time ‘advanced flow’ includes 24 hours of cooling off time. is a news editor with over a decade’s experience in journalism.

Extracellular vesicles released by mesenchymal stromal cells are widely studied as cell-free therapies because they deliver microRNAs that regulate inflammation, angiogenesis and tissue repair.